Drug Approval | February 14, 2022
Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19
Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data
Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data
Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
This is the ninth Covid-19 vaccine approved in India
Key takeaways of recent quarter & conference call highlights
The campaign aims to bring back focus on leprosy case detection, treatment and rehabilitation; especially in the context of neglect brought in by Covid-19 pandemic
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
It has signed an MoU with Plan India to expand its reach to Karnataka
Subscribe To Our Newsletter & Stay Updated
